Sandbox lung cancer differential: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(16 intermediate revisions by 2 users not shown)
Line 4: Line 4:
* '''<u>The following table summarizes the differentiation of various lung tumors based on histological and topographical features:</u>'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref>  
* '''<u>The following table summarizes the differentiation of various lung tumors based on histological and topographical features:</u>'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref>  
{| class="wikitable"
{| class="wikitable"
! colspan="11" |Benign Lung Tumors<ref name="pmid23077446">{{cite journal |vauthors=Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK |title=Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging |journal=Radiol Oncol |volume=46 |issue=2 |pages=106–13 |date=June 2012 |pmid=23077446 |pmc=3472932 |doi=10.2478/v10019-012-0021-3 |url=}}</ref>
! colspan="11" |Abrevations:
HPV: human papillomavirus; CEA: Carcino embryogenic antigen;  TTF1: '''Thyroid transcription factor-1; EMA: Epithelial membrane antigen; CK: Cyto keratin; CD: Cluster differentiation; NCAM: Neural Cell Differentiation Molecule;'''
 
MMP's: Mettaloprotineases matrix ;  GFAP: Glial fibrocilliary acid protein
|-
! colspan="11" style="background:#4479BA; color: #FFFFFF;" align="center" + |Benign Lung Tumors<ref name="pmid23077446">{{cite journal |vauthors=Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK |title=Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging |journal=Radiol Oncol |volume=46 |issue=2 |pages=106–13 |date=June 2012 |pmid=23077446 |pmc=3472932 |doi=10.2478/v10019-012-0021-3 |url=}}</ref>
|-
|-
!
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Benign lung tumor
!
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk/Epidemiology
!
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cells
!Risk/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
!Pleuripotent cells
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
!Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
!Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
!Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
!Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
!Imaging
!Mets
|-
|-
| rowspan="2" |Papilloma<ref name="pmid3969658">{{cite journal |vauthors=Maxwell RJ, Gibbons JR, O'Hara MD |title=Solitary squamous papilloma of the bronchus |journal=Thorax |volume=40 |issue=1 |pages=68–71 |date=January 1985 |pmid=3969658 |pmc=459982 |doi= |url=}}</ref>
| rowspan="2" style="background:#DCDCDC;" align="center" + |'''[[Papilloma]]'''<ref name="pmid3969658">{{cite journal |vauthors=Maxwell RJ, Gibbons JR, O'Hara MD |title=Solitary squamous papilloma of the bronchus |journal=Thorax |volume=40 |issue=1 |pages=68–71 |date=January 1985 |pmid=3969658 |pmc=459982 |doi= |url=}}</ref>
| colspan="2" |Squamous cell
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell papilloma]]'''
|
|
* HPV 6 and 11
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
* Predominantly in men
* Men
* Median age of diagnosis is 54 years
* Median age of diagnosis is 54 years
|
|
* Respiratory epithelial cells.
* [[Epithelial cells]]
|
|
* Endobronchial
* Endobronchial
Line 32: Line 35:
* Tan-white soft to semifirm protrutions
* Tan-white soft to semifirm protrutions
|
|
** Loose fibrovascular core
* Loose fibrovascular core
** Stratified squamous epithelium
* Stratified squamous epithelium
** Acanthosis
* Acanthosis
** Binucleate forms and perinuclear halos
* Binucleate forms and perinuclear halos
** Koilocytosis
* [[Koilocytosis]]
|
|
* N/A
* N/A
| rowspan="3" |
|
* Well circumscribed\
* Well circumscribed
* Homogenous
* Homogenous
* Non-calcified
* Non-calcified
Line 47: Line 50:
* N/A
* N/A
|-
|-
| colspan="2" |Glandular
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Glandular papilloma'''
|
|
* Rare
* Rare
* Mean age of diagnosis is 68
* Mean age of diagnosis is 68 years
|
|
* Goblet cells of respiratory epithelium
* [[Goblet cells]] of [[respiratory epithelium]]
|
|
* Endobronchial
* Endobronchial
|
|
* White to tan endobronchial polyps that measure from 0.7-1.5 cm
* White to tan endobronchial [[Polyp|polyps]] that measure from 0.7-1.5 cm
|
|
* Thick arborizing stromal stalks
* Thick arborizing stromal stalks
* Thin-walled blood vessels
* Thin-walled [[blood vessels]]
* Nonciliated or ciliated epithelium
* Non-ciliated or ciliated [[epithelium]]
|
|
* N/A
* N/A
|
* Well circumscribed
* Homogenous
* Non-calcified
* Solitary mass
|
|
* N/A
* N/A
|-
|-
| rowspan="3" |Adenoma<ref name="pmid9817965">{{cite journal |vauthors=Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K |title=Solitary bronchioloalveolar adenoma of the lung |journal=Respiration |volume=65 |issue=6 |pages=483–5 |date=1998 |pmid=9817965 |doi=10.1159/000029319 |url=}}</ref>
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Adenom'''a<ref name="pmid9817965">{{cite journal |vauthors=Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K |title=Solitary bronchioloalveolar adenoma of the lung |journal=Respiration |volume=65 |issue=6 |pages=483–5 |date=1998 |pmid=9817965 |doi=10.1159/000029319 |url=}}</ref>
| colspan="2" |Alveolar adenoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Alveolar adenoma'''
|
|
* Mean age of diagnosis is 53 years
* Mean age of diagnosis is 53 years
* Female predominance
* Female predominance
|
|
* Alveolar pneumocytes
* Alveolar [[pneumocytes]]
* Septal mesenchyme
* Septal [[mesenchyme]]
|
|
* All lung lobes
* All lung lobes
Line 80: Line 88:
|
|
* 0.7-6.0 cm  
* 0.7-6.0 cm  
* well demarcated smooth
* Well demarcated smooth
* Lobulated, multicystic
* Lobulated, multicystic
* Soft to firm
* Soft to firm
* Pale yellow to tan cut surfaces
* Pale yellow to tan cut surfaces
|
|
* Unencapsulated
* Non-encapsulated
* Multicystic masses
* Multicystic masses
* Cuboidal cell linning
* [[Cuboidal cells|Cuboidal cell]] linning
* Squamous metaplasia  
* Squamous metaplasia  
* Myxoid and collagenous interstitium  
* Myxoid and [[Collagen|collagenous]] interstitium  
|
|
* Keratin
* [[Keratin]]
* CEA
* [[CEA]]
* Surfactant protein  
* Surfactant protein  
* TTF-1  
* [[TTF-1]]
* Actin
* [[Actin]]
|
* Well circumscribed
* Homogenous
* Non-calcified
* Solitary mass
|
|
* N/A
* N/A
|-
|-
| colspan="2" |Papillary adenoma<ref name="pmid28409070">{{cite journal |vauthors=Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D |title=A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung |journal=Cureus |volume=9 |issue=3 |pages=e1069 |date=March 2017 |pmid=28409070 |pmc=5375953 |doi=10.7759/cureus.1069 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenoma'''<ref name="pmid28409070">{{cite journal |vauthors=Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D |title=A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung |journal=Cureus |volume=9 |issue=3 |pages=e1069 |date=March 2017 |pmid=28409070 |pmc=5375953 |doi=10.7759/cureus.1069 |url=}}</ref>
|
|
* Mean age of diagnosis is 32 years
* Mean age of diagnosis is 32 years
* Male predominance
* Male predominance
|
|
Line 115: Line 128:
* 1.0- 4.0 cm  
* 1.0- 4.0 cm  
|
|
* Infiltration.
* [[Infiltration (medical)|Infiltration]]
* Papillary growth pattern  
* [[Papillary]] growth pattern  
* Fibrovascular cores  
* Fibrovascular cores  
* Cuboidal to columnar epithelial linning
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
* Cilitated and oxyphilic cells  
* Cilitated and oxyphilic cells  
* Occasional eosinophilic intranuclear inclusions
* Occasional [[eosinophilic]] intranuclear inclusions
|
|
* Cytokeratin
* [[Cytokeratin]]
* Clara cell protein
* [[Clara cell secretory protein|Clara cell protein]]
* TTF-1
* [[TTF-1]]
* Surfactant apoprotein
* Surfactant apoprotein
* CEA.
* [[CEA]]
|
|
* Incidental finding
* Incidental finding
Line 132: Line 145:
* N/A
* N/A
|-
|-
| colspan="2" |Mucinous cystadenoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenoma'''
|
|
* No sex predilection  
* No sex predilection  
* Mean age of diagnosis is 52 years
* Mean age of diagnosis is 52 years
|
|
* Mucus glands of the bronchus
* Mucus glands of the [[bronchus]]
|
|
* Central
* Central
Line 146: Line 159:
* 0.7-7.5 cm
* 0.7-7.5 cm
|
|
* Numerous mucin-filled cystic spaces  
* Numerous [[mucin]]-filled cystic spaces  
* Non-dilated microacini, glands, tubules and papillae
* Non-dilated microacini, glands, tubules and papillae
|
|
* EMA
* EMA
* Cytokeratins  
* [[Cytokeratin|Cytokeratins]]
* CEA
* [[CEA]]
|
|
* Coin lesion.
* Coin lesion  
* Air-meniscus sign
* Air-meniscus sign
|
|
* N/A
* N/A
|-
|-
! colspan="11" |Malignant Lung Tumors<ref name="pmid7863581">{{cite journal |vauthors=Kelley LC, Puette M, Langheinrich KA, King B |title=Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry |journal=Vet. Pathol. |volume=31 |issue=6 |pages=658–62 |date=November 1994 |pmid=7863581 |doi=10.1177/030098589403100605 |url=}}</ref>
! colspan="11" style="background:#4479BA; color: #FFFFFF;" align="center" + |Malignant Lung Tumors<ref name="pmid7863581">{{cite journal |vauthors=Kelley LC, Puette M, Langheinrich KA, King B |title=Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry |journal=Vet. Pathol. |volume=31 |issue=6 |pages=658–62 |date=November 1994 |pmid=7863581 |doi=10.1177/030098589403100605 |url=}}</ref>
|-
|-
! colspan="3" |Variant of lung carci
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
 
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
mao
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
!Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
!Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
!Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
!Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
!Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
!Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
!Imaging
!Mets
|-
|-
| rowspan="4" |'''Squamous cell carcinoma'''<ref name="pmid5528918">{{cite journal |vauthors=Roth E, Smidt D |title=[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs] |language=German |journal=Berl. Munch. Tierarztl. Wochenschr. |volume=83 |issue=1 |pages=7–11 |date=January 1970 |pmid=5528918 |doi= |url=}}</ref>
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell carcinoma of the lung|Squamous cell carcinoma]] (SCC)'''<ref name="pmid5528918">{{cite journal |vauthors=Roth E, Smidt D |title=[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs] |language=German |journal=Berl. Munch. Tierarztl. Wochenschr. |volume=83 |issue=1 |pages=7–11 |date=January 1970 |pmid=5528918 |doi= |url=}}</ref>
| colspan="2" |Papillary
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary'''
| rowspan="4" |
| rowspan="3" |
* Cigarette smokers  
* Cigarette smokers  
* Arsenic  
* [[Arsenic]]
| rowspan="4" |
| rowspan="3" |
| rowspan="4" |
* Epithelial cells
| rowspan="3" |
* Central
* Central
| rowspan="4" |
| rowspan="3" |
* White or grey lesions
* White or grey lesions
* Focal carbon pigment deposits  
* Focal carbon pigment deposits  
* Cavitations.
* [[Cavitation|Cavitations]]
* Intraluminal polypoid masses  
* Intraluminal polypoid masses  
* Infiltration  
* [[Infiltration (medical)|Infiltration]]
|
|
* Exophytic  
* Exophytic  
* Intra-epithelial   
* Intra-epithelial   
* Without invasion
* Without invasion
| rowspan="4" |
| rowspan="3" |
* Keratin  
* [[Keratin]]
* Cytokeratins  
* [[Cytokeratin|Cytokeratins]]
* CEA
* [[CEA]]
* Thyroid transcription factor-1 (TTF-1)  
* [[Thyroid transcription factor-1]] ([[TTF-1]])  
| rowspan="4" |
| rowspan="3" |
* Lobar or entire lung collapse
* Lobar or entire lung collapse
* Shift of the mediastinum to the ipsilateral side.
* Shift of the [[mediastinum]] to the ipsilateral side
* Hilar, perihilar or mediastinal masses  
* Hilar, perihilar or [[Mediastinal mass|mediastinal masses]]
| rowspan="4" |
| rowspan="3" |
|-
* [[Liver]]
| colspan="2" |Clear cell
* [[Breast]]
|
* [[Bone]]
* Cells with clear cytoplasm
|-
|-
| colspan="2" |Small cell
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell'''
|
|
* Poorly differentiated cells
* Cells with clear [[cytoplasm]]
* Focal squamous
* No characteristic nuclear features of SCC.
* Intercellular bridges or keratinization.
|-
|-
| colspan="2" |Basaloid
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Basaloid'''
|
|
* Peripheral palisading of nuclei.
* Peripheral palisading of nuclei.
* Poor differentiation
* Poor differentiation
|-
|-
| colspan="3" |'''Small cell carcinoma'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref>
| colspan="3" style="background:#DCDCDC;" align="center" + |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref>
|
|
* Smoking
* [[Smoking]]
* Radon exposure
* [[Radon]] exposure
|
|
* Bronchial precursor cell
* Bronchial precursor cell
|
|
* Peripheral
|
|
* White-tan, soft, friable perihilar masses.
* White-tan, soft, friable perihilar masses  
* Extensive necrosis.
* Extensive necrosis  
* 5% peripheral coin lesions
* 5% peripheral coin lesions
|
|
* Sheet-like growth
* Sheet-like growth
* Nesting,
* Nesting  
* Trabeculae
* Trabeculae
* Peripheral palisading
* Peripheral palisading
Line 236: Line 245:
* High mitotic rate  
* High mitotic rate  
|
|
* CD56
* [[CD56]]
* Chromogranin
* [[Chromogranin]]
* Synaptophysin  
* [[Synaptophysin]]
* TTF-1
* [[TTF-1]]
|
|
* Hilar or perihilar masses  
* Hilar or perihilar masses  
* Mediastinal lymphadenopathy  
* [[Mediastinal lymphadenopathy]]
* Lobar collapse
* Lobar collapse
|
|
* Bone marrow  
* Bone marrow  
* Liver metastases
* Liver
|-
|-
| rowspan="10" |'''Adeno carcinoma<ref name="Kumar-adenocarcinoma">{{cite book |chapter=Chapter 13, box on morphology of adenocarcinoma |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |isbn=1-4160-2973-7 |edition=8th}}</ref><ref name="pmid17625570">{{cite journal| author=Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al.| title=Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. | journal=Nature | year= 2007 | volume= 448 | issue= 7153 | pages= 561-6 | pmid=17625570 | doi=10.1038/nature05945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17625570  }}</ref><ref>Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg</ref>'''
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
| colspan="2" |Acinar adenocarcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="10" style="background:#DCDCDC;" align="center" + |'''[[Adenocarcinoma]]'''<ref name="Kumar-adenocarcinoma">{{cite book |chapter=Chapter 13, box on morphology of adenocarcinoma |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |isbn=1-4160-2973-7 |edition=8th}}</ref><ref name="pmid17625570">{{cite journal| author=Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al.| title=Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. | journal=Nature | year= 2007 | volume= 448 | issue= 7153 | pages= 561-6 | pmid=17625570 | doi=10.1038/nature05945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17625570  }}</ref><ref>Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Acinar adenocarcinoma'''
| rowspan="10" |
| rowspan="10" |
* Smokers
* [[Smoking]]
| rowspan="10" |
| rowspan="10" |
* Columnar cells of bronchioles
| rowspan="10" |
| rowspan="10" |
* Peripheral
* Peripheral
Line 258: Line 278:
* Single or multiple lesions
* Single or multiple lesions
* Different in size
* Different in size
* Peripheral distribution.
* Peripheral distribution
* Gray-white central fibrosis
* Gray-white central fibrosis
* Pleural puckering  
* [[Pleural]] puckering  
* Anthracotic pigmentation.
* Anthracotic pigmentation
** Necrosis,
** [[Necrosis]]
** Cavitation
** [[Cavitation]]
** Hemorrhage.
** [[Hemorrhage]]
* Lobulated or ill defined edges.
* Lobulated or ill defined edges
|
|
* Irregular-shaped glands
* Irregular-shaped glands
* Malignant cells  
* [[Malignant]] cells:
** Hyperchromatic nuclei  
** Hyperchromatic nuclei  
** Fibroblastic stroma
** Fibroblastic stroma
| rowspan="10" |
| rowspan="10" |
* Epithelial markers (AE1/AE3, CAM 5.2)
* Epithelial markers
* Carcinoembryonic antigen
* [[CEA]]
* CK7  
* [[Cytokeratin|CK7]]
* TTF-1
* [[TTF-1]]
| rowspan="10" |
| rowspan="10" |
* Peripheral nodules under 4.0 cm in size
* Peripheral nodules under 4.0 cm in size
Line 287: Line 307:
* Adrenal glands
* Adrenal glands
* Liver
* Liver
* Kidney
* Gastrointestinal Tract
|-
|-
| colspan="2" |Papillary adenocarcinoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenocarcinoma'''
|
|
* Papillae  
* [[Papillae]]
* Necrosis
* [[Necrosis]]
* Surrounding invasion
* Surrounding invasion
* Cuboidal to columnar epithemlial linning
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
* Mucinous or non-mucinous
* [[Mucinous]] or non-mucinous
|-
|-
| rowspan="3" |Bronchio-alveolar carcinoma
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Bronchio-alveolar carcinoma'''
|Non-mucinous
| style="background:#DCDCDC;" align="center" + |'''Non-mucinous'''
|
|
* Clara cells
* [[Clara cell|Clara cells]]
* Type II cells
* [[Pneumocytes|Type II cells]]
|-
|-
|Mucinous
| style="background:#DCDCDC;" align="center" + |'''Mucinous'''
|
|
* Low grade differentiation
* Low grade differentiation
* Composed of  
* Composed of:
** Tall columnar cells  
** Tall [[Columnar epithelia|columnar cells]]
** Basal nuclei
** Basal nuclei
** Pale cytoplasm resembling goblet cells
** Pale cytoplasm resembling goblet cells
Line 312: Line 334:
* Cytologic atypia  
* Cytologic atypia  
|-
|-
|Mixed non-mucinous and mucinous or indeterminate
| style="background:#DCDCDC;" align="center" + |'''Mixed non-mucinous and mucinous or indeterminate'''
|
|
* Mixed type of cells
* Low to high grade differentiated cells.
|-
|-
| rowspan="5" |Solid adenocarcinoma with mucin production
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''Solid adenocarcinoma with mucin production'''
|Fetal adenocarcinoma
| style="background:#DCDCDC;" align="center" + |'''Fetal adenocarcinoma'''
|
|
* Consists glandular elements
* Consists glandular elements:
** Tubules of glycogen-rich
** Tubules of [[glycogen]]-rich
** Non-ciliated cells
** Non-ciliated cells
** Subnuclear and supranuclear glycogen vacuoles
** Subnuclear and supranuclear [[glycogen]] [[vacuoles]]
** Rounded morules of polygonal cells with abundant eosinophilic and finely granular cytoplasm.
** Rounded morules of polygonal cells with abundant [[eosinophilic]] and finely granular [[cytoplasm]]
|-
|-
|Mucinous (“colloid”) carcinoma
| style="background:#DCDCDC;" align="center" + |'''Mucinous (“colloid”) carcinoma'''
|
|
* Dissecting pools of mucin containing neoplastic cells.
* Dissecting pools of [[mucin]] containing [[neoplastic]] cells
|-
|-
|Mucinous cystadenocarcinoma
| style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenocarcinoma'''
|
|
* Partial fibrous tissue capsule.
* Partial [[fibrous tissue]] capsule  
* Central cystic change with mucin pooling  
* Central [[cystic]] change with [[mucin]] pooling  
* Neoplastic mucinous epithelium grows along alveolar walls.
* [[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls
|-
|-
|Signet ring adenocarcinoma
| style="background:#DCDCDC;" align="center" + |'''Signet ring adenocarcinoma'''
|
|
* Focal
* Cells with nuclei displaced to sides
* Components of other cells are present.
|-
|-
|Clear cell adenocarcinoma
| style="background:#DCDCDC;" align="center" + |'''Clear cell adenocarcinoma'''
|
|
* Clear cells with no nuclei
|-
|-
| rowspan="5" |'''Large cell carcinoma'''<ref name="pmid24221342">{{cite journal |vauthors=Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G |title=Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology |journal=Virchows Arch. |volume=464 |issue=1 |pages=61–8 |date=January 2014 |pmid=24221342 |doi=10.1007/s00428-013-1501-6 |url=}}</ref>
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
| colspan="2" |Basaloid large cell carcinoma of the lung
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]'''<ref name="pmid24221342">{{cite journal |vauthors=Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G |title=Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology |journal=Virchows Arch. |volume=464 |issue=1 |pages=61–8 |date=January 2014 |pmid=24221342 |doi=10.1007/s00428-013-1501-6 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Basaloid large cell carcinoma of the lung'''
| rowspan="5" |
| rowspan="5" |
* Approximately 10% of lung cancers.
* Approximately 10% of lung cancers
* Smoking
* [[Smoking]]
*
| rowspan="5" |
| rowspan="5" |
* Neuro endocrine cells
* [[Neuroendocrine cells|Neuro endocrine cells]]
* Suprabasal bronchial cells.
* Suprabasal bronchial cells
| rowspan="5" |
| rowspan="5" |
* Peripheral masses
* Peripheral masses
* Bronchi
* [[Bronchi]]
| rowspan="5" |
| rowspan="5" |
* Soft, pink-tan tumor  
* Soft, pink-tan tumor  


* Necrosis and occasional hemorrhage
* [[Necrosis]] and occasional [[hemorrhage]]
* Cavitations.
* [[Cavitation|Cavitations]]
* Exophytic bronchial growth  
* Exophytic bronchial growth  
|
|
Line 365: Line 402:
*[[Chromogranin]]
*[[Chromogranin]]
*[[Synaptophysin]]
*[[Synaptophysin]]
*NCAM ([[CD56]])  
*[[CD56]] 
*EBER-1 RNA +
*[[Cytokeratin]]
*Cytokeratin
| rowspan="5" |
| rowspan="5" |
* Large, peripheral masses
* Large, peripheral masses
| rowspan="5" |
| rowspan="5" |
* Pleura
* [[Pleura]]
* Liver
* [[Liver]]
* Bone
* [[Bone]]
* Brain
* [[Brain]]
* Abdominal lymph nodes
* Abdominal [[Lymph node|lymph nodes]]
* Pericardium
* [[Pericardium]]
|-
|-
| colspan="2" |Clear cell carcinoma of the lung
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell carcinoma of the lung'''
|
|
* Clear cells
* [[Clear cell|Clear cells]]
|-
|-
| colspan="2" |Lymphoepithelioma-like carcinoma of the lung
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Lymphoepithelioma-like carcinoma of the lung'''
|
|
* Syncytial growth pattern
* Syncytial growth pattern
* Eosinophilic nucleoli
* [[Eosinophilic]] nucleoli
* Lymphocytic infiltration
* [[Lymphocyte|Lymphocytic]] infiltration
* Invasive
* Invasive
* [[amyloid]] deposition
* [[Amyloid]] deposition
|-
|-
| colspan="2" |Large-cell lung carcinoma with rhabdoid phenotype
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Large-cell lung carcinoma with rhabdoid phenotype'''
|
|
* Eosinophilic cytoplasmic globules
* [[Eosinophilic]] [[cytoplasmic]] globules
* Small foci of adenocarcinoma
* Small foci of [[adenocarcinoma]]
* Eosinophilic inclusions
* [[Eosinophilic]] inclusions
|-
|-
| colspan="2" |Mixed type
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mixed type'''
|
|
* Mixture of  
* Mixture of:
** [[Adenocarcinoma]]
** [[Adenocarcinoma]]
** [[Squamous cell carcinoma]]
** [[Squamous cell carcinoma]]
Line 404: Line 440:
** Spindle cell carcinoma
** Spindle cell carcinoma
|-
|-
| rowspan="5" |'''Sarcomatoid carcinoma'''<ref name="pmid24088577">{{cite journal |vauthors=Huang SY, Shen SJ, Li XY |title=Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases |journal=World J Surg Oncol |volume=11 |issue= |pages=252 |date=October 2013 |pmid=24088577 |pmc=3850921 |doi=10.1186/1477-7819-11-252 |url=}}</ref>
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
| colspan="2" |Carcinosarcoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="5" style="background:#DCDCDC;" align="center" + |'''Sarcomatoid carcinoma'''<ref name="pmid24088577">{{cite journal |vauthors=Huang SY, Shen SJ, Li XY |title=Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases |journal=World J Surg Oncol |volume=11 |issue= |pages=252 |date=October 2013 |pmid=24088577 |pmc=3850921 |doi=10.1186/1477-7819-11-252 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Carcinosarcoma'''
| rowspan="5" |
| rowspan="5" |
* Accounts for only 0.3-1.3% of all lung malignancies
* Accounts for only 0.3-1.3% of all lung malignancies
* Mean age at diagnosis is 60 years
* Mean age at diagnosis is 60 years
* Tobacco smoking
* Tobacco [[smoking]]
* Asbestos exposure
* [[Asbestos|Asbestos exposure]]
| rowspan="5" |
| rowspan="5" |
* Undifferentiated epithelial cells  
* Undifferentiated [[epithelial cells]]
| rowspan="5" |
| rowspan="5" |
* Central or peripheral
* Central or peripheral
Line 420: Line 466:
* Well circumscribed  
* Well circumscribed  
* Grey, yellow or tan creamy, gritty,  
* Grey, yellow or tan creamy, gritty,  
* Mucoid and/or hemorrhagic with significant necrosis.
* Mucoid and/or [[hemorrhagic]] with significant [[necrosis]]
* Sessile or pedunculated  
* [[Sessile]] or [[pedunculated]]
* Infiltrative
* Infiltrative
|
|
* Biphasic
* Biphasic
* Mixture of carcinomatous and sarcomatous cells
* Mixture of [[carcinomatous]] and sarcomatous cells
|
|
* Keratin  
* [[Keratin]]
* S-100
* [[S-100]]
| rowspan="5" |
| rowspan="5" |
* No specific imaging features 
* No specific imaging features 
| rowspan="5" |
| rowspan="5" |
* Aggressive tumor
* Aggressive tumor
* Esophagus, jejunum, rectum
* [[Esophagus]], [[jejunum]], and [[rectum]]
* Kidney
* [[Kidney]]
|-
|-
| colspan="2" |Spindle cell carcinoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Spindle cell carcinoma'''
|
|
* Only spindle shaped tumor cells
* Only spindle shaped tumor cells
* Lymphoplasmacytic infiltrates
* Lymphoplasmacytic infiltrates
| rowspan="3" |
| rowspan="3" |
* Keratin  
* [[Keratin]]
* EMA  
* EMA  
* Cytokeratin
* [[Cytokeratin]]
* Vimentin,
* [[Vimentin]]
* CEA
* [[CEA]]
* TTF-1  
* [[TTF-1]]
|-
|-
| colspan="2" |Giant cell carcinoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Giant cell carcinoma'''
|
|
* Multi- and/or mononucleated tumor giant cells
* Multi- and/or mononucleated tumor [[giant cells]]
|-
|-
| colspan="2" |Pleomorphic carcinoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleomorphic carcinoma'''
|
|
* Poorly differentiated
* Poorly differentiated
* Mixture of spindle cells and/or giant cells
* Mixture of [[spindle cells]] and/or [[giant cells]]
* Fibrous or myxoid stroma
* Fibrous or myxoid [[stroma]]
|-
|-
| colspan="2" |Pulmonary blastoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary blastoma'''
|
|
* Biphasic  
* Biphasic  
* Mixture of epithelial and  mesenchymal stroma
* Mixture of [[Epithelium|epithelial]] and  mesenchymal [[Stromal cell|stroma]]
|
|
* Keratin
* [[Keratin]]
* EMA  
* EMA  
* CEA  
* [[CEA]]
* Chromogranin A  
* [[Chromogranin A]]
|-
|-
|'''Carcinoid tumor'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
| colspan="2" |Typical carcinoid
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
Atypical carcinoid  
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| style="background:#DCDCDC;" align="center" + |'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Typical carcinoid'''
'''Atypical carcinoid'''
|
|
* Most common in males
* Mean age of diagnosis 45
|
|
* Neuroendocrine cells of lung
* [[Neuroendocrine cells]] of lung
|
|
* Typical carcinoids are throughout the lungs  
* Typical [[Carcinoid|carcinoids]] are throughout the lungs  


* AC is more commonly peripheral
* Atypical carcinoid is more commonly peripheral
|
|
* Firm, well demarcated, tan to yellow tumors.
* Firm, well demarcated, tan to yellow tumors  
|
|
* Uniform polygonal cells  
* Uniform polygonal cells  
* Nuclear atypia  
* Nuclear atypia  
* Pleomorphism  
* [[Pleomorphism]]
* The most common patterns are the organoid and trabecular  
* The most common patterns are the organoid and trabecular  
* Highly vascularized fibrovascular stroma
* Highly vascularized fibrovascular stroma
* Focal necrosis
* Focal [[necrosis]]
|
|
* Cytokeratin  
* [[Cytokeratin]]
* Chromogranin
* [[Chromogranin]]
* Synaptophysin
* [[Synaptophysin]]
* Leu-7 (CD57)
* [[CD57]]
* N-CAM (CD56)
* [[CD56]]
* S-100 protein
* [[S-100 protein]]
|
|
* Well defined pulmonary nodules
* Well defined [[pulmonary]] nodules
* Calcifications is often seen.  
* [[Calcification|Calcifications]] is often seen.  
* Intense contrast enhancement.
* Intense contrast enhancement
|
|
* Liver  
* [[Liver]]
* Bone
* [[Bone]]
|-
|-
| rowspan="3" |'''Salivary gland tumors'''  
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>
| colspan="2" |Mucoepidermoid carcinoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Mucoepidermoid carcinoma]]'''
|
|
* Most patients presents in the third and fourth decade
* Most patients presents in the third and fourth decade
* Constitutes of less than 1% tumor
* Constitutes of less than 1% tumor
* No association with cigarette smoking or other risk factors.
* No association with [[cigarette smoking]] or other risk factors
|
|
* Primitive cells of tracheobronchial origin
* Primitive cells of tracheobronchial origin
Line 518: Line 576:
|
|
* Exophytic endobronchial growth
* Exophytic endobronchial growth
* Surface epithelium lacking changes of insitu carcinoma
* Surface [[epithelium]] lacking changes of in-situ [[carcinoma]]
* Absence of individual cell keratinization
* Absence of individual cell [[keratinization]]
* Transitional areas to low grade mucoepidermoid carcinoma.
* Transitional areas to low grade [[mucoepidermoid carcinoma]]
|
|
*  
* [[GFAP]]
|
|
* Well-circumscribed oval or lobulated mass
* Well-circumscribed oval or lobulated mass
* Calcifications
* [[Calcification|Calcifications]]
* Post-obstructive pneumonic infiltrates
* Post-obstructive pneumonic infiltrates
|
|
* Rare
* Rare
* Liver
* [[Liver]]
* Bones
* [[Bones]]
* Adrenal gland
* [[Adrenal gland]]
* Brain
* [[Brain]]
|-
|-
| colspan="2" |Adenoid cystic carcinoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Adenoid cystic carcinoma'''
|
|
* Constitutes less than 1% of all lung tumors.
* Constitutes less than 1% of all lung tumors
* Most commonly seen in fourth and fifth decades of life
* Most commonly seen in fourth and fifth decades of life
|
|
* Primitive cells of tracheobronchial origin
* Primitive cells of tracheobronchial origin
|
|
* Trachea
* [[Trachea]]
|
|
* Gray-white or tan polypoid lesions.
* Gray-white or tan polypoid lesions


* Size ranges from 1–4 cm  
* Size ranges from 1–4 cm  


* Infiltrative margins.
* Infiltrative margins
|
|
* Invades other cell layers.
* Invades other cell layers
* Heterogeneous cellularity
* Heterogeneous cellularity
* Cribriform pattern  
* Cribriform pattern  
* Perineural invasion
* Perineural invasion
|
|
* Immunoperoxidase  
* [[Immunoperoxidase]]
* Cytokeratin  
* [[Cytokeratin]]
* Vimentin
* [[Vimentin]]
* Actin
* [[Actin]]
* Calponin
* [[Calponin]]
* S-100 protein
* [[S-100 protein]]
* p63
* [[p53]]
* GFAP
* [[GFAP]]
|
|
* Well circumscribed
* Nodule
|
|
* Liver
* [[Liver]]
* Brain
* [[Brain]]
* Bone
* [[Bone]]
* Spleen
* [[Spleen]]
* Kidney
* [[Kidney]]
* Adrenal glands
* [[Adrenal glands]]
|-
|-
| colspan="2" |Epithelial-myoepithelial carcinoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelial-myoepithelial carcinoma'''
|
|
* Age ranges from 33 to 71 years  
* Age ranges from 33 to 71 years  
* No association between smoking
* No association with [[smoking]]
|
|
*Myoepithelial cells
*[[Myoepithelial cells]]
|
|
* Endobronchia
* Endobronchial
|
|
* Solid to gelatinous in texture
* Solid to gelatinous in texture
* White to gray in colour
* White to gray in colour
|
|
* Myoepithelial cells
* [[Myoepithelial cells]]
* Dual layer of cells lining ducts.
* Dual layer of cells lining ducts
* Low mitotic activity.
* Low mitotic activity
|
|
* MNF116  
* MNF116  
* EMA
* EMA
* SMA and S-100
* [[SMA]] and [[S-100]]
|
|
* Reflects airway obstruction
* Reflects [[airway obstruction]]
|
|
* [[Breast]]
|-
|-
| rowspan="3" |'''Preinvasive lesions'''  
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
| colspan="2" |Squamous carcinoma in situ  
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Squamous carcinoma in situ'''
| rowspan="3" |
| rowspan="3" |
* Most commonly seen in fifth or sixth decades
* Most commonly seen in fifth or sixth decades
Line 602: Line 673:
* Basal cells of squamous epithelium
* Basal cells of squamous epithelium
|
|
* Bronchi
* [[Bronchi]]
|
|
* Focal or multi-focal plaque-like greyish lesions  
* Focal or multi-focal plaque-like greyish lesions  
* Nonspecific erythema  
* Nonspecific [[erythema]]
* Even nodular or polypoid lesions
* Even nodular or polypoid lesions
|
|
* Goblet cell hyperplasia
* [[Goblet cell]] [[hyperplasia]]


* Basal cell hyperplasia
* [[Basal cell]] [[hyperplasia]]


* Squamous dysplasia  
* [[Squamous]] [[dysplasia]]


* Angiogenic squamous dysplasia  
* [[Angiogenic]] [[squamous]] [[dysplasia]]


* Micropapillomatosis
* Micropapillomatosis
|
|
* EGFR  
* [[EGFR]]
* HER2/neu   
* [[HER2/neu]]  
* p53  
* [[P53 (protein)|p53]]
* MCM2  
* [[MCM2]]
* Ki-67  
* [[Ki-67]]
* Cytokeratin 5/6  
* [[Cytokeratin|Cytokeratin 5/6]]
* bcl-2  
* [[Bcl-2]]
* VEGF  
* [[VEGF]]
* Folate binding protein  
* Folate binding protein  
* p16
* [[P16 (gene)|p16]]
|
|
|
* Cauliflower like
* Mosaic pattern
| rowspan="3" |
* [[Liver]]
* [[Brain]]
* [[Bone]]
* [[Spleen]]
|-
|-
| colspan="2" |Atypical adenomatous hyperplasia  
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Atypical adenomatous hyperplasia'''
|
|
* Surfactant apoprotein  
* Surfactant apoprotein  
* Clara cell specific 10kDd protein
* [[Clara cell secretory protein|Clara cell specific 10kDd protein]]
|
|
* Pleura  
* [[Pleurae|Pleura]]
* Upper lobes
* Upper lobes
|
|
* Multiple grey to yellow foci  
* Multiple grey to yellow foci  
* 1mm to 10mm in size.
* 1mm to 10mm in size
|
|
* Intranuclear inclusions
* Intranuclear inclusions
* Clara cells and type II pneumocytes.
* [[Clara cell|Clara cells]] and [[Pneumocytes|type II pneumocytes]]
* Thickened alveolar walls  
* Thickened alveolar walls  
* Discontinuous lining of cells
* Discontinuous lining of cells
* Moderate atypia.
* Moderate atypia
* Pseudopapillae
* Pseudopapillae
|
|
* CEA  
* [[CEA]]
* MMPs  
* [[MMP|MMPs]]
* E-cadherin,
* [[E-cadherin]]
* ß-catenin,
* [[Beta-catenin|ß-catenin]]
* CD44v6  
* [[CD44|CD44v6]]
* TTF-1
* [[TTF-1]]
* TP53  
* [[TP53]]
|
|
* Typically not visualized on radiographs.
* Typically not visualized on [[Radiography|radiographs]]
* Small non-solid nodules
* Small non-solid nodules


* Ground glass opacity  
* Ground-glass opacity  
|
|-
|-
| colspan="2" |Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'''
|
|
* Pulmonary neuroendocrine cells
* [[Pulmonary]] [[neuroendocrine cells]]
|
|
* Endobronchial
* Endobronchial
|
|
* Early lesions
* Early lesions are:
** Small, gray-white nodules
** Small, gray-white nodules
** Resembling ‘miliary bodies’  
** Resembling ‘miliary bodies’  
* Larger carcinoid tumors are
* Larger [[carcinoid]] tumors are:
** Firm
** Firm
** Homogeneous
** Homogeneous
** Well-defined
** Well-defined
** Grey or yellow-white masses.
** Grey or yellow-white masses  
|
|
* Nodular aggregates
* [[Nodular]] aggregates
* Fibrosis due to proliferation
* [[Myelofibrosis|Fibrosis]] due to [[proliferation]]
* Invade locally
* Invade locally
* Fibrous stroma aggregates to form ‘tumorlets’.
* [[Fibrous]] [[stroma]] aggregates to form ‘tumorlets’.
* Carcinoids are tumorlets >5cm.
* [[Carcinoid|Carcinoids]] are tumorlets >5cm.
|
|
* [[Keratin]]
* [[CEA]]
|
|
* Mosaic pattern of air trapping
* Mosaic pattern of air trapping
* Sometimes with nodules
* Sometimes with nodules
* Thickened bronchial and bronchiolar walls
* Thickened [[bronchial]] and bronchiolar walls
|
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Risk Factors/Epidemiology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pleuripotent cell
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Topography
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gross
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Immunohistochemistry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Imaging
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
|-
| rowspan="8" |'''Mesenchymal tumors'''  
| rowspan="8" style="background:#DCDCDC;" align="center" + |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>
| colspan="2" |Epithelioid haemangioendothelioma / Angiosarcoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelioid haemangioendothelioma / Angiosarcoma'''
|
|
* Caucasian
* Caucasian
* 80% are women.
* 80% are women
|
|
* Endothelial cells
* Endothelial cells
|
|
* Intravascular
* [[Intravascular]]
|
|
* 0.3-2.0 cm circumscribed mass
* 0.3-2.0 cm circumscribed mass
* Gray-white or gray-tan firm tissue
* Gray-white or gray-tan firm tissue
* Yellow flecks
* Yellow flecks
* Central calcifications
* Central [[Calcification|calcifications]]
* Cut surface has a cartilaginous consistency.  
* Cut surface has a [[cartilaginous]] consistency   
|
|
* Round to oval-shaped nodules
* Round to oval-shaped [[nodules]]
** Central sclerosis
* Central [[sclerosis]]
** Hypocellular zone  
* Hypocellular zone  
** Peripheral cellular zone
* Peripheral cellular zone
** Calcifications
* [[Calcification|Calcifications]]
** Intranuclear cytoplasmic inclusions
* Intranuclear [[cytoplasmic]] [[inclusions]]
|
|
* CD31
* [[CD31]]
* CD34
* [[CD34]]
* factor VIII (von Willebrand factor)
* [[Factor VIII]] ([[von Willebrand factor]])
* Fli1
* [[Cytokeratin]]
* FKBP12
* Cytokeratin  
|
|
* Multiple
* Multiple
* Bilateral
* Bilateral
* Small nodules  
* Small nodules  
* 1-2 cm in size.
* 1-2 cm in size  
* Can mimic pulmonary Langerhans’ cell histiocytosis.
* Can mimic [[Langerhans cell histiocytosis|pulmonary Langerhans’ cell histiocytosis]].
* Calcifications
* [[Calcification|Calcifications]]
|
|
* Liver
* [[Liver]]
* Bone  
* [[Bone]]
* Soft tissue
* [[Soft tissue]]
|-
|-
| colspan="2" |Pleuropulmonary blastoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleuropulmonary blastoma'''
|
|
* Most common in children
* Most common in children
* Median age of diagnosis is 2 years.
* Median age of diagnosis is 2 years
|
|
* Thoracic splanchnopleural mesenchyme.
* [[Thoracic]] splanchnopleural [[mesenchyme]]
|
|
* Pleura  
* [[Pleurae|Pleura]]
* Lung
* [[Lung]]
|
|
* Purely cystic  
* Purely cystic  
Line 748: Line 833:
|
|
* Type I
* Type I
** Purely cystic
** Purely [[cystic]]
** Lined by respiratory type epithelium
** Lined by [[respiratory]] type [[epithelium]]
** Underneath malignant cells
** Underneath [[malignant]] [[cells]]
* Type II
* Type II
** Partial or complete overgrowth of the septal stroma
** Partial or complete overgrowth of the septal [[stroma]]
* Type III
* Type III
** Mixed cells
** Mixed cells
|
|
* Vimentin
* [[Vimentin]]
* S-100 protein
* [[S-100 protein]]
|
|
* Unilateral  
* Unilateral  
Line 763: Line 848:
* Septal thickening or an intracystic mass
* Septal thickening or an intracystic mass
|
|
* Brain
* [[Brain]]
* Spinal cord  
* [[Spinal cord]]
* Skeletal system
* [[Skeletal system]]
* Eyes
* [[Eye|Eyes]]
* Pancreas
* [[Pancreas]]
|-
|-
| colspan="2" |Chondroma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Chondroma'''
|
|
* Young women
* Young women
|
|
* Chondrocytes,
* [[Chondrocyte|Chondrocytes]]
* Cartilaginous cells
* Cartilaginous cells
|
|
* Peripheral lesions in lung
* Peripheral lesions in [[lung]]
* 1<sup>o</sup> seen in
* Primary lesion seen in
** Stomach
** [[Stomach]]
** Bone
** [[Bone]]
** Paraganglia
** [[Paraganglia]]
|
|
* Peripheral  
* Peripheral  
* Solid lesions
* Solid lesions
* Calcified
* [[Calcified lesion|Calcified]]
|
|
* Capsulated lobules  
* Capsulated lobules  
* Hypocellular
* Hypocellular
* Features of malignancy are absent
* Features of [[malignancy]] are absent
|
|
* N/A
* N/A
Line 796: Line 881:
* “Pop-corn” calcifications
* “Pop-corn” calcifications
|
|
* Benign tumor
* [[Benign tumor|Benign]] in nature
|-
|-
| colspan="2" |Congenital peribronchial myofibroblastic tumor
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Congenital peribronchial myofibroblastic tumor'''
|
|
* Rare
* Rare
* Sporadic
* Sporadic
* Complicated by  
* Complicated by  
** Polydramnios
** [[Polyhydramnios]]
** Non-immune hydrops fetalis
** [[Hydrops fetalis|Non-immune hydrops fetalis]]
|
|
* Spindle cells
* [[Spindle cells]]
|
|
* Along the bronchi
|
|
* 5-10 cm  
* 5-10 cm  
Line 813: Line 899:
* Non-encapsulated
* Non-encapsulated
* Smooth or multinodular surface
* Smooth or multinodular surface
* The cut surface has a tann-grey to yellow-tan fleshy appearance.
* The cut surface has a tann-grey to yellow-tan fleshy appearance
** Haemorrhage
* [[Hemorrhage]]
** Necrosis
* [[Necrosis]]
|
|
* Fascicles of spindle cells.
* [[Fascicles]] of [[spindle cells]]
* Bronchial invasion  
* [[Bronchial]] invasion  
* Peribronchial distribution
* Peribronchial distribution
* Cystic foci of haemorrhage
* Cystic foci of [[hemorrhage]]
|
|
* Vimentin
* [[Vimentin]]
|
|
* Well circumscribed  
* Well circumscribed  
* Opacifying the hemithorax
* Opaque hemithorax
* Heterogeneous mass
* Heterogeneous mass
|
|
* Rare
|-
|-
| colspan="2" |Diffuse pulmonary lymphangiomatosis
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse pulmonary lymphangiomatosis'''
|
|
* Children
* Children
* Young adults of both sexes
* Young adults of both sexes
|
|
* Smooth muscles cells of lymphatic vessels.
* [[Smooth muscle cells]] of [[lymphatic vessels]]
|
|
* Along the lymphatic distribution.
* Along the [[Lymphatic drainage|lymphatic distribution]]
|
|
* Prominence of the bronchovascular bundles along
* Prominence of the bronchovascular bundles along
** Pleura
** [[Pleurae|Pleura]]
** Interlobular pulmonary septa
** Interlobular pulmonary septa
** Mediastinum
** [[Mediastinum]]
|
|
* Anastomosing endothelial-lined cells along lymphatic routes.
* Anastomosing endothelial-lined cells along lymphatic routes


* Spindle cells
* [[Spindle cells]]
* Intra alveolar siderophages
* Intra alveolar siderophages
|
|
* FVIIIrAg
* [[Vimentin]]
* Vimentin  
* UEA
|
|
* Increased interstitial markings
* Increased interstitial markings


* Thickening of the  
* Thickening of the:
** Interlobular septa  
** Interlobular septa  
** Fissures
** [[Fissure|Fissures]]
** Central airways  
** Central airways  
** Pleura
** [[Pleura]]
|
|
* Skin
* Bone
|-
|-
| colspan="2" |Inflammatory myofibroblastic tumor
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Inflammatory myofibroblastic tumor'''
|
|
* Previous viral infections
* Previous [[viral infections]]
* HHV8
* [[HHV-8|HHV8]]
* Children
* Children
|
|
* Myofibroblastic cells
* [[Myofibroblasts|Myofibroblastic cells]]
|
|
* Localized to bronchia
* Localized to bronchi
|
|
* Solitary
* Solitary
Line 877: Line 964:
* Yellowish-gray discoloration
* Yellowish-gray discoloration
* Average size of 3.0 cm
* Average size of 3.0 cm
* Non encapculated  
* Non-encapculated  
* Calcifications  
* [[Calcification|Calcifications]]
* No local invasion
* No local invasion
|
|
* Mixture of spindle cells  
* Mixture of [[spindle cells]]
** Fibroblastic  
** [[Fibroblastic]]
** Myofibroblastic
** [[Myofibroblasts|Myofibroblastic]]
* Arranged in fascicles  
* Arranged in [[fascicles]]
* Cytologic atypia  
* Cytologic atypia  
* Touton type giant cells.
* Touton type [[giant cells]]
* Plasma cells  
* [[Plasma cells]]
* Lymphoid follicles
* [[Lymphoid follicles]]
|
|
* Vimentin  
* [[Vimentin]]
* Actin
* [[Actin]]
* ALK1
* p80
* p80
|
|
Line 899: Line 985:
* Spiculated appearance
* Spiculated appearance
* Accompanied by  
* Accompanied by  
** Post-obstructive pneumonia  
** Post-obstructive [[pneumonia]]
** Atelectasis
** [[Atelectasis]]
|
|
* Rare
* Rare
|-
|-
| colspan="2" |Pulmonary artery sarcoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary artery sarcoma'''
|
|
* Mean age of diagnosis is 49.3 years
* Mean age of diagnosis is 49.3 years
* Commonly misdiagnosed as PE
* Commonly misdiagnosed as [[pulmonary embolism]]
|
|
* Mesenchymal cells of the intima  
* [[Mesenchymal cell|Mesenchymal cells]] of the [[intima]]
* Primitive cells of the bulbus cordi in the trunk of pulmonary artery.
* Primitive cells of the bulbus cordi in the trunk of [[pulmonary artery]]
|
|
* Pulmonary trunk most commonly
* [[Pulmonary trunk]] most commonly involving:
** Right pulmonary artery
** [[Right pulmonary artery]]
** Left pulmonary artery
** [[Left pulmonary artery]]
** Pulmonary valve,
** [[Pulmonary valve]]
** Right ventricular outflow tract
** [[Ventricular outflow tract|Right ventricular outflow tract]]
|
|
* Mucoid or gelatinous clots filling vascular lumens
* Mucoid or gelatinous clots filling vascular lumens
Line 922: Line 1,008:
** Firm fibrotic areas
** Firm fibrotic areas
** Bony/gritty or chondromyxoid foci
** Bony/gritty or chondromyxoid foci
** Haemorrhage and necrosis are common in high-grade tumors
** [[Hemorrhage]] and [[necrosis]] are common in high-grade tumors
|
|
* Spindle cells in
* Spindle cells in
Line 929: Line 1,015:
** Recanalized thrombi  
** Recanalized thrombi  
|
|
* Vimentin
* [[Vimentin]]
* Osteopontin
* [[Osteopontin]]
* Factor VIII
* [[Factor VIII]]
* CD31
* [[CD31]]
* CD34
* [[CD34]]
|
| rowspan="2" |
* Findings overlap with those of chronic thromboembolic disease
* Findings overlap with those of chronic [[thromboembolic disease]]
* Decreased vascularity  
* Decreased [[vascularity]]
* Heterogeneous soft tissue density
* Heterogeneous [[soft tissue]] density
* Smooth vascular tapering  
* Smooth [[vascular]] tapering  
|
|
* Lung  
* [[Lung]] parenchyma
* Mediastinum
* [[Mediastinum]]
|-
|-
| colspan="2" |Pulmonary vein sarcoma
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary vein sarcoma'''
|
|
* Most common in women.
* Most common in women
* Mean age of diagnosis is 49.
* Mean age of diagnosis is 49
|
|
* Smooth muscle
* [[Smooth muscle]]
|
|
* Pulmonary vein
* [[Pulmonary veins|Pulmonary vein]]
|
|
* Fleshy-tan tumor
* Fleshy-tan tumor
* Can occlude the lumen of the involved vessel.
* Can occlude the lumen of the involved vessel
* 3.0- 20.0 cm
* 3.0- 20.0 cm
* Invasion of wall of the vein.
* Invasion of wall of the [[vein]]
|
|
* Smooth muscle differentiation
* [[Smooth muscle]] differentiation
* Moderate to highly cellular spindle cell neoplasms  
* Moderate to highly cellular [[Spindle cells|spindle cell]] [[neoplasms]]
* Epithelioid morphology  
* [[Epithelioid]] morphology  
|
* Vimentin
* Desmin and actin
* Keratin
|
|
* [[Vimentin]]
* [[Desmin]]
* [[Actin]]
* [[Keratin]]
|
|
* N/A
* N/A
Line 970: Line 1,056:


== Differentiation of lung cancer from other diseases with similar presentation ==
== Differentiation of lung cancer from other diseases with similar presentation ==
'''The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.<ref name="pmid4353362">{{cite journal |vauthors=Chaudhuri MR |title=Primary pulmonary cavitating carcinomas |journal=Thorax |volume=28 |issue=3 |pages=354–66 |year=1973 |pmid=4353362 |pmc=470041 |doi= |url=}}</ref><ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref><ref name="pmid10377211">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid103772112">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref>'''
'''The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.'''<ref name="pmid4353362">{{cite journal |vauthors=Chaudhuri MR |title=Primary pulmonary cavitating carcinomas |journal=Thorax |volume=28 |issue=3 |pages=354–66 |year=1973 |pmid=4353362 |pmc=470041 |doi= |url=}}</ref><ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref><ref name="pmid10377211">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid103772112">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref>
{| class="wikitable"
{| class="wikitable"
! rowspan="3" |Disease
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
! colspan="9" |Clinical features
! colspan="9" style="background:#4479BA; color: #FFFFFF;" align="center" + |Clinical features
Signs & symptoms
Signs & symptoms
! rowspan="3" |Radiological Findings
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Radiological Findings
! rowspan="3" |Characterstic feature
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Characterstic feature
|-
|-
| colspan="2" |Fever
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Fever
| colspan="2" |Cough
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Cough
| rowspan="2" |Hemoptysis
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Hemoptysis
| rowspan="2" |Dyspnea
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Dyspnea
| rowspan="2" |Chest pain
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Chest pain
| rowspan="2" |Weight loss
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Weight loss
| rowspan="2" |Night sweats
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Night sweats
|-
|-
|High-grade
! style="background:#4479BA; color: #FFFFFF;" align="center" + |High-grade
|Low grade
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Low grade
|Productive
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Productive
|Dry
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Dry
|-
|-
|Acute Lung abscess
| style="background:#DCDCDC;" align="center" + |Acute Lung abscess
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,000: Line 1,086:
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|'''-'''
|
|
*Air fluid level
*Air fluid level
Line 1,008: Line 1,094:
*Associated with risk factors like [[aspiration]] and [[alcoholism]]
*Associated with risk factors like [[aspiration]] and [[alcoholism]]
|-
|-
|[[Malignancy]]
| style="background:#DCDCDC;" align="center" + |[[Malignancy]]
([[Lung cancer|primary lung cancer]])
([[Lung cancer|primary lung cancer]])
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,024: Line 1,110:
*Ground glass opacities 
*Ground glass opacities 
|
|
*Long H/o smoking
*Long h/o [[smoking]]
*Elderly male or female
*Elderly male or female
*BAL positive for [[malignant]] [[cells]]
*[[Bronchoalveolar lavage|Broncho-alveolar lavage]] positive for [[malignant]] [[cells]]
*CT guided [[biopsy]] is required for confirmation and differnatiation
*CT guided [[biopsy]] is required for confirmation and differentiation
|-
|-
|[[Tuberculosis, pulmonary|Pulmonary Tuberculosis]]
| style="background:#DCDCDC;" align="center" + |[[Tuberculosis, pulmonary|Pulmonary Tuberculosis]]
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,040: Line 1,126:
| +
| +
|
|
*Cavitations in the upper lobe of the [[lung]]
*[[Cavitation|Cavitations]] in the upper lobe of the [[lung]]
|
|
*People in [[Endemic (epidemiology)|endemic]] at high risk
*People in [[Endemic (epidemiology)|endemic]] at high risk
Line 1,046: Line 1,132:
*[[Acid fast|Acid fast stain]] positive for [[Mycobacterium|mycobacteria]]
*[[Acid fast|Acid fast stain]] positive for [[Mycobacterium|mycobacteria]]
|-
|-
|[[Pneumonia|Necrotizing Pneumonia]]
| style="background:#DCDCDC;" align="center" + |[[Pneumonia|Necrotizing Pneumonia]]
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,059: Line 1,145:
*Multiple cavitary lesions
*Multiple cavitary lesions
|
|
*Acute life threatening condition
*Acute life-threatening condition
*Complication of [[pneumonia]] or lung abscess
*Complication of [[pneumonia]] or [[lung abscess]]
*Multiple [[organisms]] responsible
*Multiple [[organisms]] responsible
*prompt treatment with [[antibiotics]] is required
*Prompt treatment with [[antibiotics]] is required
*CBC positive for causative organism
*[[Blood culture]] positive for causative organism
|-
|-
|Empyema
| style="background:#DCDCDC;" align="center" + |Empyema
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,078: Line 1,164:
*Homogeneous [[Consolidation (medicine)|consolidation]]<nowiki/>s
*Homogeneous [[Consolidation (medicine)|consolidation]]<nowiki/>s
|
|
*Blood culture positive for causative agent.
*[[Blood culture]] positive for the causative agent
|-
|-
|[[Bronchiectasis]]
| style="background:#DCDCDC;" align="center" + |[[Bronchiectasis]]
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,097: Line 1,183:
*Increased [[pulmonary]] markings
*Increased [[pulmonary]] markings
*Honeycombing
*Honeycombing
*[[atelectasis]]  
*[[Atelectasis]]  
|
|
* CT confirms the diagnosis .
* CT confirms the diagnosis
|-
|-
|[[Wegener's granulomatosis|Wegners granulomatosis]]
| style="background:#DCDCDC;" align="center" + |[[Wegener's granulomatosis|Wegners granulomatosis]]
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,113: Line 1,199:
|
|
*[[Pulmonary]] [[nodules]]  
*[[Pulmonary]] [[nodules]]  
*[[cavities]]
*[[Cavities]]
*Infiltrates
*Infiltrates
|
|
Line 1,120: Line 1,206:
*Biopsy of involved [[Organ (anatomy)|organ]] confirms [[granulomas]]
*Biopsy of involved [[Organ (anatomy)|organ]] confirms [[granulomas]]
|-
|-
|[[Sarcoidosis]]
| style="background:#DCDCDC;" align="center" + |[[Sarcoidosis]]
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,138: Line 1,224:
**Biposy findings: [[epithelioid]],granulomas, schaumann, asteroid bodies.
**Biposy findings: [[epithelioid]],granulomas, schaumann, asteroid bodies.
|-
|-
|[[Rheumatoid nodule]]
| style="background:#DCDCDC;" align="center" + |[[Rheumatoid nodule]]
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,150: Line 1,236:
|
|
*[[Pulmonary]] [[nodules]]
*[[Pulmonary]] [[nodules]]
*Cavitations on the upper lobe pf lung.
*[[Cavitation|Cavitations]] on the upper lobe of lung
|
|
*[[Rheumatoid arthritis]]
*[[Rheumatoid arthritis]]
*Positive for [[Rheumatoid factor|RF]] and ACP
*Positive for [[Rheumatoid factor|RF]] and ACP
|-
|-
|[[Langerhans cell histiocytosis|Langerhans cell Histiocytosis]]
| style="background:#DCDCDC;" align="center" + |[[Langerhans cell histiocytosis|Langerhans cell Histiocytosis]]
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,168: Line 1,254:
*Thin-walled cystic cavities
*Thin-walled cystic cavities
|
|
*Exclusively afflicts smokers.
*Exclusively afflicts smokers
*[[Musculoskeletal]] and [[skin]] is involved
*[[Musculoskeletal]] and [[skin]] is involved
*Biopsy of the involved organ
*Biopsy of the involved organ
|-
|-
|[[Bronchiolitis obliterans]]
| style="background:#DCDCDC;" align="center" + |[[Bronchiolitis obliterans]]
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,187: Line 1,273:
* Ground-glass opacities  
* Ground-glass opacities  


* Nodules.
* [[Nodules]]
|
|
* Biopsy
* Biopsy

Latest revision as of 19:12, 22 March 2018

  • Differentiation of primary and secondary lung tumors is difficult due to overlapping histologic features.
  • Topography, size and form of pulmonary growth pattern are important aspects for the differential diagnosis.
  • The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[1]
Abrevations:

HPV: human papillomavirus; CEA: Carcino embryogenic antigen; TTF1: Thyroid transcription factor-1; EMA: Epithelial membrane antigen; CK: Cyto keratin; CD: Cluster differentiation; NCAM: Neural Cell Differentiation Molecule;

MMP's: Mettaloprotineases matrix ; GFAP: Glial fibrocilliary acid protein

Benign Lung Tumors[2]
Benign lung tumor Risk/Epidemiology Pleuripotent cells Topography Gross Histology Immunohistochemistry Imaging Metastasis
Papilloma[3] Squamous cell papilloma
  • HPV 6 and 11
  • Men
  • Median age of diagnosis is 54 years
  • Endobronchial
  • Cauliflower-like lesions
  • Tan-white soft to semifirm protrutions
  • Loose fibrovascular core
  • Stratified squamous epithelium
  • Acanthosis
  • Binucleate forms and perinuclear halos
  • Koilocytosis
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Glandular papilloma
  • Rare
  • Mean age of diagnosis is 68 years
  • Endobronchial
  • White to tan endobronchial polyps that measure from 0.7-1.5 cm
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Adenoma[4] Alveolar adenoma
  • Mean age of diagnosis is 53 years
  • Female predominance
  • All lung lobes
  • Lower lobes
  • Hilar
  • 0.7-6.0 cm
  • Well demarcated smooth
  • Lobulated, multicystic
  • Soft to firm
  • Pale yellow to tan cut surfaces
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Papillary adenoma[5]
  • Mean age of diagnosis is 32 years
  • Male predominance
  • Bronchioloalveolar cell
  • No lobar predilection
  • Involves alveolar parenchyma
  • Well defined
  • Encapsulated
  • Soft, spongy to firm mass
  • Granular gray white/ brown
  • 1.0- 4.0 cm
  • Incidental finding
  • N/A
Mucinous cystadenoma
  • No sex predilection
  • Mean age of diagnosis is 52 years
  • Central
  • White-pink to tan
  • Smooth and shiny tumors
  • Gelatinous mucoid solid core
  • 0.7-7.5 cm
  • Numerous mucin-filled cystic spaces
  • Non-dilated microacini, glands, tubules and papillae
  • Coin lesion
  • Air-meniscus sign
  • N/A
Malignant Lung Tumors[6]
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Squamous cell carcinoma (SCC)[7] Papillary
  • Epithelial cells
  • Central
  • Exophytic
  • Intra-epithelial
  • Without invasion
Clear cell
Basaloid
  • Peripheral palisading of nuclei.
  • Poor differentiation
Small cell carcinoma[8]
  • Bronchial precursor cell
  • Peripheral
  • White-tan, soft, friable perihilar masses
  • Extensive necrosis
  • 5% peripheral coin lesions
  • Sheet-like growth
  • Nesting
  • Trabeculae
  • Peripheral palisading
  • Rosette formation
  • High mitotic rate
  • Bone marrow
  • Liver
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Adenocarcinoma[9][10][11] Acinar adenocarcinoma
  • Columnar cells of bronchioles
  • Peripheral
  • Single or multiple lesions
  • Different in size
  • Peripheral distribution
  • Gray-white central fibrosis
  • Pleural puckering
  • Anthracotic pigmentation
  • Lobulated or ill defined edges
  • Irregular-shaped glands
  • Malignant cells:
    • Hyperchromatic nuclei
    • Fibroblastic stroma
  • Peripheral nodules under 4.0 cm in size
  • Central location as a hilar or perihilar mass
  • Rarely show cavitations.
  • Hilar adenopathy
  • Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
Aerogenous spread is characteristic
  • Brain
  • Bone
  • Adrenal glands
  • Liver
  • Kidney
  • Gastrointestinal Tract
Papillary adenocarcinoma
Bronchio-alveolar carcinoma Non-mucinous
Mucinous
  • Low grade differentiation
  • Composed of:
    • Tall columnar cells
    • Basal nuclei
    • Pale cytoplasm resembling goblet cells
    • Varying amounts of cytoplasmic mucin
  • Cytologic atypia
Mixed non-mucinous and mucinous or indeterminate
  • Mixed type of cells
  • Low to high grade differentiated cells.
Solid adenocarcinoma with mucin production Fetal adenocarcinoma
Mucinous (“colloid”) carcinoma
Mucinous cystadenocarcinoma
Signet ring adenocarcinoma
  • Focal
  • Cells with nuclei displaced to sides
  • Components of other cells are present.
Clear cell adenocarcinoma
  • Clear cells with no nuclei
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Large cell carcinoma[12] Basaloid large cell carcinoma of the lung
  • Approximately 10% of lung cancers
  • Smoking
  • Soft, pink-tan tumor
  • Invasive growth pattern
  • Peripheral palisading
  • Small, monomorphic, cuboidal fusiform
  • Large, peripheral masses
Clear cell carcinoma of the lung
Lymphoepithelioma-like carcinoma of the lung
Large-cell lung carcinoma with rhabdoid phenotype
Mixed type
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Sarcomatoid carcinoma[13] Carcinosarcoma
  • Central or peripheral
  • Upper lobes
  • No specific imaging features 
Spindle cell carcinoma
  • Only spindle shaped tumor cells
  • Lymphoplasmacytic infiltrates
Giant cell carcinoma
Pleomorphic carcinoma
Pulmonary blastoma
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Carcinoid tumor[14] Typical carcinoid

Atypical carcinoid

  • Most common in males
  • Mean age of diagnosis 45
  • Atypical carcinoid is more commonly peripheral
  • Firm, well demarcated, tan to yellow tumors
  • Uniform polygonal cells
  • Nuclear atypia
  • Pleomorphism
  • The most common patterns are the organoid and trabecular
  • Highly vascularized fibrovascular stroma
  • Focal necrosis
Salivary gland tumors[15] Mucoepidermoid carcinoma
  • Most patients presents in the third and fourth decade
  • Constitutes of less than 1% tumor
  • No association with cigarette smoking or other risk factors
  • Primitive cells of tracheobronchial origin
  • Bronchial glands
  • Ranging in size from 0.5-6 cm
  • Soft, polypoid, and pink-tan in colour
  • High-grade lesions are infiltrative
  • Well-circumscribed oval or lobulated mass
  • Calcifications
  • Post-obstructive pneumonic infiltrates
Adenoid cystic carcinoma
  • Constitutes less than 1% of all lung tumors
  • Most commonly seen in fourth and fifth decades of life
  • Primitive cells of tracheobronchial origin
  • Gray-white or tan polypoid lesions
  • Size ranges from 1–4 cm
  • Infiltrative margins
  • Invades other cell layers
  • Heterogeneous cellularity
  • Cribriform pattern
  • Perineural invasion
  • Well circumscribed
  • Nodule
Epithelial-myoepithelial carcinoma
  • Age ranges from 33 to 71 years
  • No association with smoking
  • Endobronchial
  • Solid to gelatinous in texture
  • White to gray in colour
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Preinvasive lesions[16] Squamous carcinoma in situ
  • Most commonly seen in fifth or sixth decades
  • Mostly seen in women
  • Basal cells of squamous epithelium
  • Focal or multi-focal plaque-like greyish lesions
  • Nonspecific erythema
  • Even nodular or polypoid lesions
  • Micropapillomatosis
  • Cauliflower like
  • Mosaic pattern
Atypical adenomatous hyperplasia
  • Multiple grey to yellow foci
  • 1mm to 10mm in size
  • Typically not visualized on radiographs
  • Small non-solid nodules
  • Ground-glass opacity
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Endobronchial
  • Early lesions are:
    • Small, gray-white nodules
    • Resembling ‘miliary bodies’
  • Larger carcinoid tumors are:
    • Firm
    • Homogeneous
    • Well-defined
    • Grey or yellow-white masses
  • Mosaic pattern of air trapping
  • Sometimes with nodules
  • Thickened bronchial and bronchiolar walls
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Mesenchymal tumors[17] Epithelioid haemangioendothelioma / Angiosarcoma
  • Caucasian
  • 80% are women
  • Endothelial cells
  • 0.3-2.0 cm circumscribed mass
  • Gray-white or gray-tan firm tissue
  • Yellow flecks
  • Central calcifications
  • Cut surface has a cartilaginous consistency
Pleuropulmonary blastoma
  • Most common in children
  • Median age of diagnosis is 2 years
  • Purely cystic
  • Thin-walled
  • Rarely solid
  • Firm to gelatinous
  • Upto 15 cm
  • Unilateral
  • Localized airfilled cysts
  • Septal thickening or an intracystic mass
Chondroma
  • Young women
  • Capsulated lobules
  • Hypocellular
  • Features of malignancy are absent
  • N/A
  • Multiple
  • Well circumscribed lesions
  • “Pop-corn” calcifications
Congenital peribronchial myofibroblastic tumor
  • Along the bronchi
  • 5-10 cm
  • Well-circumscribed
  • Non-encapsulated
  • Smooth or multinodular surface
  • The cut surface has a tann-grey to yellow-tan fleshy appearance
  • Hemorrhage
  • Necrosis
  • Well circumscribed
  • Opaque hemithorax
  • Heterogeneous mass
  • Rare
Diffuse pulmonary lymphangiomatosis
  • Children
  • Young adults of both sexes
  • Prominence of the bronchovascular bundles along
  • Anastomosing endothelial-lined cells along lymphatic routes
  • Increased interstitial markings
  • Skin
  • Bone
Inflammatory myofibroblastic tumor
  • Localized to bronchi
  • Solitary
  • Round rubbery masses
  • Yellowish-gray discoloration
  • Average size of 3.0 cm
  • Non-encapculated
  • Calcifications
  • No local invasion
  • Solitary mass
  • Regular borders
  • Spiculated appearance
  • Accompanied by
  • Rare
Pulmonary artery sarcoma
  • Mucoid or gelatinous clots filling vascular lumens
  • The cut surface may show
    • Firm fibrotic areas
    • Bony/gritty or chondromyxoid foci
    • Hemorrhage and necrosis are common in high-grade tumors
  • Spindle cells in
    • A myxoid background
    • Collagenized stroma
    • Recanalized thrombi
Pulmonary vein sarcoma
  • Most common in women
  • Mean age of diagnosis is 49
  • Fleshy-tan tumor
  • Can occlude the lumen of the involved vessel
  • 3.0- 20.0 cm
  • Invasion of wall of the vein
  • N/A

Differentiation of lung cancer from other diseases with similar presentation

The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.[18][19][20][21][22]

Disease Clinical features

Signs & symptoms

Radiological Findings Characterstic feature
Fever Cough Hemoptysis Dyspnea Chest pain Weight loss Night sweats
High-grade Low grade Productive Dry
Acute Lung abscess + - + - - - + - -
  • Air fluid level
Malignancy

(primary lung cancer)

- + - + + - - + +
  • Coin-shaped lesion
  • Thick wall(>15mm)
  • Ground glass opacities 
Pulmonary Tuberculosis + - + - + - - - +
Necrotizing Pneumonia + - + + - + - -
  • Multiple cavitary lesions
Empyema + - + - + + + - -
Bronchiectasis - - + - + - - - -
  • Linear lucencies
  • Tram tracking appearance
  • Clustered cysts
  • CT confirms the diagnosis
Wegners granulomatosis - - + + + - - -
  • Seen mostly in female age group of 40-55 years
  • Traid of Upper , lower respiratory tract and kidney disease
  • Biopsy of involved organ confirms granulomas
Sarcoidosis + - + - + - - + +
Rheumatoid nodule - - - - - + - + -
Langerhans cell Histiocytosis - - - - - + + + -
  • Thin-walled cystic cavities
Bronchiolitis obliterans - - + - + + + - -
  • Ground-glass opacities
  • Biopsy

References

  1. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
  2. Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
  3. Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
  4. Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
  5. Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
  6. Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
  7. Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
  8. Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
  9. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
  10. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
  11. Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
  12. Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
  13. Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
  14. Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
  15. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
  16. Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
  17. Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
  18. Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
  19. Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
  20. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  21. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  22. Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.